Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive — Page 4 of 7
-
October 2, 2019
Research team sorts out drug screen false positive results
Vanderbilt investigators have identified 13 previously unknown drug compounds that cause false positive screenings for amphetamines, buprenorphine (an opioid), cannabinoids and methadone. -
September 10, 2019
Relational memory in early psychosis
Studies of relational memory function may reveal novel mechanisms for therapeutic intervention for patients in the early stages of psychosis. -
August 15, 2019
REDCap data management tool reaches million user mark
Fifteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has reached 1 million users throughout the world. -
July 11, 2019
Working memory in psychotic disorders
Functional MRI studies have revealed that targeting activation of certain brain regions may improve working memory and cognition in psychotic disorders. -
July 8, 2019
Clinical study tests drug that may prevent cancer metastasis
A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center. -
September 27, 2018
Clinic helps adults clarify true status of penicillin allergy
-
August 14, 2018
Medically underserved women in the Southeast rarely receive BRCA tests
Medically underserved women in the Southeast diagnosed with breast cancer or ovarian cancer missed out on genetic testing that could have helped them and their relatives make important decisions about their health, according to new research from Vanderbilt-Ingram Cancer Center.